Advanced Therapy Medicinal Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Therapy Type (Cell Therapy, CAR-T Therapy, Gene Therapy, Tissue Engineered Product); Application (Cancer, Cystic Fibrosis, Muscular Dystrophy, Hemophilia, Alzheimer, Others) and Geography

Report Code: TIPRE00012921 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Advanced therapy medicinal products consist of cell therapies, gene therapies, and tissue-engineered products. These products are highly complex treatments that differ from traditional medicines. These products have different manufacturing processes and in the route of administration. Regulatory agencies regulate these types of products. Many regional regulatory agencies are approving gene therapies, cell therapies and tissue engineered products.

MARKET DYNAMICS

The advanced therapy medicinal products market is driving due to the rise in product approvals by regulatory agency, and benefits associated with use of the advanced therapy. However, high cost associated with therapies of advanced therapy medicinal products are expected to hamper the growth of the global Advanced Therapy Medicinal Products market.

MARKET SCOPE

The "Advanced Therapy Medicinal Products Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of advanced therapy medicinal products market with detailed market segmentation by therapy type and application. The advanced therapy medicinal products market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in advanced therapy medicinal products market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Advanced Therapy Medicinal Products market is segmented on the basis of therapy type and application. Based on therapy type, the market is segmented as Cell Therapy, CAR-T Therapy, Gene Therapy and Tissue Engineered Product. On the basis of application, the market is categorized as Cancer, Cystic Fibrosis, Muscular Dystrophy, Hemophilia, Alzheimer and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Advanced Therapy Medicinal Products market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Advanced Therapy Medicinal Products market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Advanced Therapy Medicinal Products market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Advanced Therapy Medicinal Products market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Advanced Therapy Medicinal Products market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Advanced Therapy Medicinal Products market are anticipated to have lucrative growth opportunities in the future with the rising demand for Advanced Therapy Medicinal Products in the global market. Below mentioned is the list of few companies engaged in the Advanced Therapy Medicinal Products market.
The report also includes the profiles of key players in Advanced Therapy Medicinal Products market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Novartis AG
  •  Gilead Sciences, Inc.
  •  Vericel Corporation
  •  PHARMICELL Co., Ltd
  •  BioMarin
  •  bluebird bio, Inc.
  •  Pfizer Inc.
  •  uniQure N.V.
  •  Kolon TissueGene, Inc.
  •  JCR Pharmaceuticals Co., Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Advanced Therapy Medicinal Products Market - By Therapy Type
1.3.2 Advanced Therapy Medicinal Products Market - By Application
1.3.3 Advanced Therapy Medicinal Products Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ADVANCED THERAPY MEDICINAL PRODUCTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ADVANCED THERAPY MEDICINAL PRODUCTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ADVANCED THERAPY MEDICINAL PRODUCTS MARKET - GLOBAL MARKET ANALYSIS
6.1. ADVANCED THERAPY MEDICINAL PRODUCTS - GLOBAL MARKET OVERVIEW
6.2. ADVANCED THERAPY MEDICINAL PRODUCTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. ADVANCED THERAPY MEDICINAL PRODUCTS MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY TYPE
7.1. OVERVIEW
7.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
7.3. CELL THERAPY
7.3.1. Overview
7.3.2. Cell Therapy Market Forecast and Analysis
7.3.3. Stem Cell Therapy Market
7.3.3.1. Overview
7.3.3.2. Stem Cell Therapy Market Forecast and Analysis
7.3.4. Non-stem Cell Therapy Market
7.3.4.1. Overview
7.3.4.2. Non-stem Cell Therapy Market Forecast and Analysis
7.4. CAR-T THERAPY
7.4.1. Overview
7.4.2. CAR-T Therapy Market Forecast and Analysis
7.5. GENE THERAPY
7.5.1. Overview
7.5.2. Gene Therapy Market Forecast and Analysis
7.6. TISSUE ENGINEERED PRODUCT
7.6.1. Overview
7.6.2. Tissue Engineered Product Market Forecast and Analysis
8. ADVANCED THERAPY MEDICINAL PRODUCTS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER
8.3.1. Overview
8.3.2. Cancer Market Forecast and Analysis
8.4. CYSTIC FIBROSIS
8.4.1. Overview
8.4.2. Cystic Fibrosis Market Forecast and Analysis
8.5. MUSCULAR DYSTROPHY
8.5.1. Overview
8.5.2. Muscular Dystrophy Market Forecast and Analysis
8.6. HEMOPHILIA
8.6.1. Overview
8.6.2. Hemophilia Market Forecast and Analysis
8.7. ALZHEIMER
8.7.1. Overview
8.7.2. Alzheimer Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis

9. ADVANCED THERAPY MEDICINAL PRODUCTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Advanced Therapy Medicinal Products Market Overview
9.1.2 North America Advanced Therapy Medicinal Products Market Forecasts and Analysis
9.1.3 North America Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Therapy Type
9.1.4 North America Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Application
9.1.5 North America Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Countries
9.1.5.1 United States Advanced Therapy Medicinal Products Market
9.1.5.1.1 United States Advanced Therapy Medicinal Products Market by Therapy Type
9.1.5.1.2 United States Advanced Therapy Medicinal Products Market by Application
9.1.5.2 Canada Advanced Therapy Medicinal Products Market
9.1.5.2.1 Canada Advanced Therapy Medicinal Products Market by Therapy Type
9.1.5.2.2 Canada Advanced Therapy Medicinal Products Market by Application
9.1.5.3 Mexico Advanced Therapy Medicinal Products Market
9.1.5.3.1 Mexico Advanced Therapy Medicinal Products Market by Therapy Type
9.1.5.3.2 Mexico Advanced Therapy Medicinal Products Market by Application
9.2. EUROPE
9.2.1 Europe Advanced Therapy Medicinal Products Market Overview
9.2.2 Europe Advanced Therapy Medicinal Products Market Forecasts and Analysis
9.2.3 Europe Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Therapy Type
9.2.4 Europe Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Application
9.2.5 Europe Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Advanced Therapy Medicinal Products Market
9.2.5.1.1 Germany Advanced Therapy Medicinal Products Market by Therapy Type
9.2.5.1.2 Germany Advanced Therapy Medicinal Products Market by Application
9.2.5.2 France Advanced Therapy Medicinal Products Market
9.2.5.2.1 France Advanced Therapy Medicinal Products Market by Therapy Type
9.2.5.2.2 France Advanced Therapy Medicinal Products Market by Application
9.2.5.3 Italy Advanced Therapy Medicinal Products Market
9.2.5.3.1 Italy Advanced Therapy Medicinal Products Market by Therapy Type
9.2.5.3.2 Italy Advanced Therapy Medicinal Products Market by Application
9.2.5.4 Spain Advanced Therapy Medicinal Products Market
9.2.5.4.1 Spain Advanced Therapy Medicinal Products Market by Therapy Type
9.2.5.4.2 Spain Advanced Therapy Medicinal Products Market by Application
9.2.5.5 United Kingdom Advanced Therapy Medicinal Products Market
9.2.5.5.1 United Kingdom Advanced Therapy Medicinal Products Market by Therapy Type
9.2.5.5.2 United Kingdom Advanced Therapy Medicinal Products Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Advanced Therapy Medicinal Products Market Overview
9.3.2 Asia-Pacific Advanced Therapy Medicinal Products Market Forecasts and Analysis
9.3.3 Asia-Pacific Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Therapy Type
9.3.4 Asia-Pacific Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Advanced Therapy Medicinal Products Market
9.3.5.1.1 Australia Advanced Therapy Medicinal Products Market by Therapy Type
9.3.5.1.2 Australia Advanced Therapy Medicinal Products Market by Application
9.3.5.2 China Advanced Therapy Medicinal Products Market
9.3.5.2.1 China Advanced Therapy Medicinal Products Market by Therapy Type
9.3.5.2.2 China Advanced Therapy Medicinal Products Market by Application
9.3.5.3 India Advanced Therapy Medicinal Products Market
9.3.5.3.1 India Advanced Therapy Medicinal Products Market by Therapy Type
9.3.5.3.2 India Advanced Therapy Medicinal Products Market by Application
9.3.5.4 Japan Advanced Therapy Medicinal Products Market
9.3.5.4.1 Japan Advanced Therapy Medicinal Products Market by Therapy Type
9.3.5.4.2 Japan Advanced Therapy Medicinal Products Market by Application
9.3.5.5 South Korea Advanced Therapy Medicinal Products Market
9.3.5.5.1 South Korea Advanced Therapy Medicinal Products Market by Therapy Type
9.3.5.5.2 South Korea Advanced Therapy Medicinal Products Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Advanced Therapy Medicinal Products Market Overview
9.4.2 Middle East and Africa Advanced Therapy Medicinal Products Market Forecasts and Analysis
9.4.3 Middle East and Africa Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Therapy Type
9.4.4 Middle East and Africa Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Advanced Therapy Medicinal Products Market
9.4.5.1.1 South Africa Advanced Therapy Medicinal Products Market by Therapy Type
9.4.5.1.2 South Africa Advanced Therapy Medicinal Products Market by Application
9.4.5.2 Saudi Arabia Advanced Therapy Medicinal Products Market
9.4.5.2.1 Saudi Arabia Advanced Therapy Medicinal Products Market by Therapy Type
9.4.5.2.2 Saudi Arabia Advanced Therapy Medicinal Products Market by Application
9.4.5.3 U.A.E Advanced Therapy Medicinal Products Market
9.4.5.3.1 U.A.E Advanced Therapy Medicinal Products Market by Therapy Type
9.4.5.3.2 U.A.E Advanced Therapy Medicinal Products Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Advanced Therapy Medicinal Products Market Overview
9.5.2 South and Central America Advanced Therapy Medicinal Products Market Forecasts and Analysis
9.5.3 South and Central America Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Therapy Type
9.5.4 South and Central America Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Application
9.5.5 South and Central America Advanced Therapy Medicinal Products Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Advanced Therapy Medicinal Products Market
9.5.5.1.1 Brazil Advanced Therapy Medicinal Products Market by Therapy Type
9.5.5.1.2 Brazil Advanced Therapy Medicinal Products Market by Application
9.5.5.2 Argentina Advanced Therapy Medicinal Products Market
9.5.5.2.1 Argentina Advanced Therapy Medicinal Products Market by Therapy Type
9.5.5.2.2 Argentina Advanced Therapy Medicinal Products Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ADVANCED THERAPY MEDICINAL PRODUCTS MARKET, KEY COMPANY PROFILES
11.1. NOVARTIS AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GILEAD SCIENCES, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. VERICEL CORPORATION
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. PHARMICELL CO., LTD
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BIOMARIN
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BLUEBIRD BIO, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PFIZER INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. UNIQURE N.V.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. KOLON TISSUEGENE, INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. JCR PHARMACEUTICALS CO., LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis AG
2. Gilead Sciences, Inc.
3. Vericel Corporation
4. PHARMICELL Co., Ltd
5. BioMarin
6. bluebird bio, Inc.
7. Pfizer Inc.
8. uniQure N.V.
9. Kolon TissueGene, Inc.
10. JCR Pharmaceuticals Co., Ltd.
TIPRE00012921
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking